Epilepsy Trial, Recruiting NCT04322734 Sponsor: Southwest Autism Research & Resource Center Condition: Epilepsy
Back to Epilepsy

Epilepsy Trial, Recruiting

NCT04322734
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Children and teenagers with Autism Spectrum Disorder (ASD), confirmed by a recognized diagnostic assessment or evaluation by the lead doctor, who are between birth and 17 years and 11 months old
  • Children and teenagers between birth and 17 years and 11 months old who have been diagnosed with a typical development, movement disorder, epilepsy, brain tumor, or a psychiatric condition

Who may not be able to join:

  • Children who have had a serious bad reaction to having blood drawn in the past
  • Females of reproductive age who are pregnant or planning to become pregnant during the trial
  • Children who have any other history or information that the lead doctor believes is a reason they should not take part (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 15 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Richard E Frye, MD, PhD, Autism Discovery & Treatment Foundation

Phone: 844-ADTFRes

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Southwest Autism Research & Resource Center
Registry
ClinicalTrials.gov
Start date
13 December 2023
Est. completion
31 December 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Mitochondrial Reserve Capacity measured using the Seahorse XR Flux Analyzer

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov